Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases
Open accessThe DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Abstract
Engineered model of the human gut-liver-brain axis can be used to study the link between the microbiome and Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This connection has been confirmed using an OoC setup that emulates the immune–metabolic crosstalk between these tissues103.”
From Human disease models in drug development (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multi-omics and multiplexed cytokine and chemokine analysis revealed that short-chain fatty acids increase the expression of pathways related to ferroptosis in Parkinson disease models”
From Human disease models in drug development (2023) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Research works printed but not linked: 1
- F. Yang, B. Li, L. Li, H. Zhang, The clinical significance of the imbalance of Th17 and Treg cells and their related cytokines in peripheral blood of Parkinson’s disease patients. Int. J. Clin. Exp. Med. 9, 17946–17951 (2016).
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 187
Fully 3D-printed soft robots with integrated fluidic circuitry
Hubbard, J. D., Acevedo, R., Edwards, K. M., Alsharhan, A. T., Wen, Z., Landry, J., Wang, K., Schaffer, S., & Sochol, R. D. (2021) · Science Advances · doi:10.1126/sciadv.abe5257 · Cited by 179
Tao, T., Deng, P., Wang, Y., Zhang, X., Guo, Y., Chen, W., & Qin, J. (2022) · Advanced Science · doi:10.1002/advs.202103495 · Cited by 178
Straehla, J. P., Hajal, C., Safford, H. C., Offeddu, G. S., Boehnke, N., Dacoba, T. G., Wyckoff, J., Kamm, R. D., & Hammond, P. T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118697119 · Cited by 152
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 157
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Xie, A., Ensink, E., Li, P., Gordevičius, J., Marshall, L. L., George, S., Pospisilik, J. A., Aho, V. T. E., Houser, M. C., Pereira, P. A. B., et al. (2022) · Movement Disorders · doi:10.1002/mds.29128 · Cited by 117
The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology
Guo, Y., Chen, X., Gong, P., Li, G., Yao, W., & Yang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044089 · Cited by 114
Experimental models of Parkinson's disease: Challenges and Opportunities
Lal, R., Singh, A., watts, S., & Chopra, K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176819 · Cited by 95
Intestinal organ chips for disease modelling and personalized medicine
Özkan, A., LoGrande, N., Feitor, J. F., Goyal, G., & Ingber, D. E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00968-3 · Cited by 109
Microfluidic Gut-on-a-Chip: Fundamentals and Challenges
Thomas, D. P., Zhang, J., Nguyen, N., & Ta, H. T. (2023) · Biosensors · doi:10.3390/bios13010136 · Cited by 95
Organ on Chip Technology to Model Cancer Growth and Metastasis
Imparato, G., Urciuolo, F., & Netti, P. A. (2022) · Bioengineering · doi:10.3390/bioengineering9010028 · Cited by 82
Microbiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 79
Asif, A., Park, S. H., Soomro, A. M., Khalid, M. A. U., Salih, A. R. C., Kang, B., Ahmed, F., Kim, K. H., & Choi, K. H. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.03.035 · Cited by 78
Revolutionizing immune research with organoid-based co-culture and chip systems
Papp, D., Korcsmáros, T., & Hautefort, I. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae004 · Cited by 75
Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
Blanchard, J., Victor, M. B., & Tsai, L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00578-6 · Cited by 73
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 72
Organoid technologies for the study of intestinal microbiota–host interactions
Bozzetti, V., & Senger, S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.02.001 · Cited by 75
In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
Kaur, S., Kidambi, S., Ortega-Ribera, M., Thuy, L. T. T., Nieto, N., Cogger, V. C., Xie, W.-F., Tacke, F., & Gracia-Sancho, J. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.11.008 · Cited by 65
Harnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak-Novakovic, G. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.05.008 · Cited by 63
Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models
Wu, L., Ai, Y., Xie, R., Xiong, J., Wang, Y., & Liang, Q. (2023) · Lab on a Chip · doi:10.1039/d2lc00804a · Cited by 69
Wang, T., Tao, S., Wu, Y., An, T., Lv, B., Liu, J.-X., Liu, Y.-T., & Jiang, G. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00329-22 · Cited by 78
Madhav, H., Jameel, E., Rehan, M., & Hoda, N. (2022) · RSC Medicinal Chemistry · doi:10.1039/d1md00394a · Cited by 65
Micro/nanosystems for controllable drug delivery to the brain
Tian, M., Ma, Z., & Yang, G. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100548 · Cited by 80
In vitro models to study human gut-microbiota interactions: Applications, advances, and limitations
Qi, Y., Yu, L., Tian, F., Zhao, J., & Zhai, Q. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127336 · Cited by 72
Maoz, B. M. (2021) · APL Bioengineering · doi:10.1063/5.0055812 · Cited by 66
Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis
Li, C., Yao, J., Yang, C., Yu, S., Yang, Z., Wang, L., Li, S., & He, N. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01554-5 · Cited by 69
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
Advances in human organoids-on-chips in biomedical research
Wang, Y., & Qin, J. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad007 · Cited by 61
Shafagh, R. Z., Youhanna, S. C., Keulen, J., Shen, J. X., Taebnia, N., Preiss, L. C., Klein, K., Büttner, F., Bergqvist, M., van der Wijngaart, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202203368 · Cited by 60
Integrated biosensors for monitoring microphysiological systems
Mou, L., Mandal, K., Mecwan, M. M., Hernández, A. L., Maity, S., Sharma, S., Herculano, R. D., Kawakita, S., Jucaud, V., Dokmeci, M. R., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00262k · Cited by 57
Kim, M., van Noort, D., Sung, J. H., & Park, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413513 · Cited by 48
Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 55
The Synergy between Deep Learning and Organs-on-Chips for High-Throughput Drug Screening: A Review
Dai, M., Xiao, G., Shao, M., & Zhang, Y. S. (2023) · Biosensors · doi:10.3390/bios13030389 · Cited by 50
A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis
Kang, S., Kimura, M., Shrestha, S., Lewis, P., Lee, S., Cai, Y., Joshi, P., Acharya, P., Liu, J., Yang, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302502 · Cited by 44
Self-citationKoenig, L., Ramme, A. P., Faust, D., Mayer, M., Flötke, T., Gerhartl, A., Brachner, A., Neuhaus, W., Appelt‐Menzel, A., Metzger, M., et al. (2022) · Cells · doi:10.3390/cells11203295 · Cited by 52
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetologia · doi:10.1007/s00125-024-06198-1 · Cited by 61
Stem cells, organoids, and organ-on-a-chip models for personalized in vitro drug testing
van Berlo, D., Nguyen, V. V. T., Gkouzioti, V., Leineweber, K., Verhaar, M. C., & van Balkom, B. W. M. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.08.006 · Cited by 48
Recent Advances in Gut‐ and Gut–Organ‐Axis‐on‐a‐Chip Models
Kim, R., & Sung, J. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302777 · Cited by 53
Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development
Mulay, A. R., Hwang, J., & Kim, D. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303180 · Cited by 39
Advancing Intelligent Organ‐on‐a‐Chip Systems with Comprehensive In Situ Bioanalysis
Li, X., Zhu, H. J., Gu, B., Yao, C., Gu, Y., Xu, W., Zhang, J., He, J., Liu, X., & Li, D. (2023) · Advanced Materials · doi:10.1002/adma.202305268 · Cited by 50
Zhu, Y., Jiang, D., Qiu, Y. L., Liu, X., Bian, Y., Tian, S., Wang, X., Hsia, K. J., Wan, H., Zhuang, L., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.019 · Cited by 53
Small tissue chips with big opportunities for space medicine
Mu, X., He, W., Rivera, V. A. M., Alba, R. A. D. D., Newman, D. J., & Zhang, Y. S. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.09.002 · Cited by 40
Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Zhang, Q., Xing, W., Wang, Q., Tang, Z., Wang, Y., & Gao, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.934113 · Cited by 43
Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine
Li, Z., Li, Q., Zhou, C., Lu, K., Liu, Y., Xuan, L., & Wang, X. (2023) · Biomicrofluidics · doi:10.1063/5.0171350 · Cited by 36
Zhang, J., Huang, Y.-J., Trapečar, M., Wright, C. W., Schneider, K., Kemmitt, J., Hernandez‐Gordillo, V., Yoon, J. Y., Poyet, M., Alm, E. J., et al. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00501-z · Cited by 40
Self-citationPramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 39
Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease
Wheeler, A., Stoeger, V., & Owens, R. M. (2024) · Lab on a Chip · doi:10.1039/d3lc00877k · Cited by 32
Engineering organoids-on-chips for drug testing and evaluation
Wang, H., Zhu, W., Xu, C., Su, W., & Li, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156065 · Cited by 32
Cook, S. R., Ball, A. G., Mohammad, A., & Pompano, R. R. (2024) · Lab on a Chip · doi:10.1039/d4lc00489b · Cited by 34
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetes Care · doi:10.2337/dci24-0052 · Cited by 50
Advances in gut–brain organ chips
Zhang, Y., Lu, S., Zhuang, J., & Liang, L. (2024) · Cell Proliferation · doi:10.1111/cpr.13724 · Cited by 34
Yang, J., Zhang, X., Liu, Z., Yang, C., Li, S., Zhou, H., & Gao, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155882 · Cited by 30
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 28
Fusco, F., Perottoni, S., Giordano, C., Riva, A., Iannone, L. F., Caro, C. D., Russo, E., Albani, D., & Striano, P. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10296 · Cited by 29
Developing Liver Microphysiological Systems for Biomedical Applications
Wang, J., Wu, X., Zhao, J., Ren, H., & Zhao, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302217 · Cited by 27
Organ-on-a-Chip Models—New Possibilities in Experimental Science and Disease Modeling
Wysoczański, B., Świątek, M., & Wójcik-Gładysz, A. (2024) · Biomolecules · doi:10.3390/biom14121569 · Cited by 29
Modeling gut neuro-epithelial connections in a novel microfluidic device
de Hoyos‐Vega, J. M., Yu, X., Gonzalez‐Suarez, A. M., Chen, S., Mercado‐Perez, A., Krueger, E. W., Hernandez, J., Fedyshyn, Y., Druliner, B. R., Linden, D. R., et al. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00615-y · Cited by 34
Taavitsainen, S., Juuti‐Uusitalo, K., Kurppa, K., Lindfors, K., Kallio, P. J., & Kellomäki, M. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2023.1337945 · Cited by 32
Technological advances and challenges in constructing complex gut organoid systems
Zheng, L., Zhan, Y., Wang, C., Fan, Q., Sun, D., Li, Y., & Xiong, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1432744 · Cited by 29
Kim, J. J., Bae, M., & Cho, D. (2024) · Small Science · doi:10.1002/smsc.202400314 · Cited by 29
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetes · doi:10.2337/dbi24-0028 · Cited by 35
Challenges and Opportunities Modeling the Dynamic Tumor Matrisome
Peyton, S. R., Platt, M. O., & Cukierman, E. (2023) · BME Frontiers · doi:10.34133/bmef.0006 · Cited by 25
Use and application of organ-on-a-chip platforms in cancer research
Yu, Y., Zhou, T., & Cao, L.-L. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00790-7 · Cited by 31
Boylin, K., Aquino, G. V., Purdon, M., Abedi, K., Kasendra, M. J., & Barrile, R. (2024) · Biofabrication · doi:10.1088/1758-5090/ad4c08 · Cited by 21
Bahitham, W., Alghamdi, S., Omer, I., Alsudais, A. S., Hakeem, I., Alghamdi, A., Abualnaja, R., Sanai, F. M., Rosado, A. S., & Sergi, C. M. (2024) · Biomedicines · doi:10.3390/biomedicines12030550 · Cited by 24
Sadiq, I. Z., Abubakar, F. S., Katsayal, B. S., Ibrahim, B., Adamu, A., Usman, M. A., Aliyu, M., Suleiman, M. A., & Muhammad, A. (2025) · Biomedical Engineering Advances · doi:10.1016/j.bea.2025.100172 · Cited by 31
Getting closer to modeling the gut-brain axis using induced pluripotent stem cells
Hall, V. J., & Bendtsen, K. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146062 · Cited by 23
New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axis
Moradian, H., Gabriel-Segard, T., Barrau, M., Roblin, X., & Paul, S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2351520 · Cited by 24
Reassessing neurodegenerative disease: immune protection pathways and antagonistic pleiotropy
Provenzano, F., & Deleidi, M. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.006 · Cited by 21
Trapečar, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.14260 · Cited by 22
Flinkman, D., Hong, Y., Gnjatovic, J., Deshpande, P., Ortutay, Z., Peltonen, S., Kaasinen, V., James, P., & Coffey, E. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00460-w · Cited by 20
Trends in organ-on-a-chip for pharmacological analysis
Xu, X., Cheung, S., Jia, X., Fan, G., Ai, Y., Zhang, Y., & Liang, Q. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117905 · Cited by 24
Microphysiological systems to advance human pathophysiology and translational medicine
Harriot, A. D., Ward, C. W., & Kim, D. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00087.2024 · Cited by 23
A new tissue-agnostic microfluidic device to model physiology and disease: the lattice platform
Campo, H., Zha, D., Pattarawat, P., Colina, J. A., Zhang, D., Murphy, A. R., Yoon, J., Russo, A., Rogers, H. B., Lee, H. C., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00378g · Cited by 19
Establishment of advanced tumor organoids with emerging innovative technologies
Mao, Y., & Hu, H. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217122 · Cited by 20
Advances and applications of organ-on-a-chip technology
Kong, J. S., Kim, J., Jang, J., & Cho, D.-W. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101361 · Cited by 20
Yeap, Y. J., Tng, T. J. W., Lee, M. J., Goh, M., & Lim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032523 · Cited by 23
Self-citationAdvanced tissue engineering for in vitro drug safety testing
Owens, R. M. (2023) · MRS Communications · doi:10.1557/s43579-023-00421-7 · Cited by 20
Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner
Liu, W., Fan, M., Lu, W., Zhu, W., Meng, L., & Lu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.872167 · Cited by 20
Gabriel-Segard, T., Rontard, J., Miny, L., Dubuisson, L., Batut, A., Debis, D., Gleyzes, M., Francois, F., Larramendy, F., Soriano, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310568 · Cited by 14
New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target
Xing, Y., Ou, Y., Wang, Y., Hou, L., & Zhu, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117284 · Cited by 13
Innovative engineering approaches to model host-microbiome interactions in vitro
Azamar, K. M. M., Sudi, S. D., Mohammadalizadeh, Z., Coffin, C., Parker, I., & Porras, A. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115677 · Cited by 15
Modelling the innate immune system in microphysiological systems
Rupar, M. J., Hanson, H. M., Rogers, S., Botlick, B. L., Trimmer, S. J., & Hickman, J. J. (2024) · Lab on a Chip · doi:10.1039/d3lc00812f · Cited by 16
Han, H., & Jang, J. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.931411 · Cited by 14
Modeling neurodegenerative diseases with brain organoids: from development to disease applications
Larriba-González, T., García-Martín, M., Ojeda-Hernández, D. D., Rincón-Cerrada, P., Martín-Blanco, L., Benito‐Martín, M. S., Selma-Calvo, B., de la Fuente-Martín, S., Matías‐Guiu, J. A., Matías‐Guiu, J., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1663286 · Cited by 13
Bioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology
Shin, Y. C., Than, N., Park, S. J., & Kim, H. J. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2365254 · Cited by 14
The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
Dhanawat, M., Garima, G., Wilson, K., Gupta, S., Gupta, N., & Sardana, S. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273302508240613114103 · Cited by 13
Liao, Y., Chai, D., Wang, Q., Wang, X., Yong, Q., Cheng, Z., Zhang, C., Zhang, D., Liu, B., Liu, R., et al. (2024) · Materials Horizons · doi:10.1039/d4mh01174k · Cited by 14
Advances and applications of gut organoids: modeling intestinal diseases and therapeutic development
Xu, X., Zhang, Y., Huang, G., Perekatt, A. O., Wang, Y., & Chen, L. (2025) · Life Medicine · doi:10.1093/lifemedi/lnaf012 · Cited by 20
Kršek, A., Schleicher, L. M. S., Jagodic, A., & Batičić, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189178 · Cited by 15
From organ to system: multiorgan-on-a-chip platforms as next-generation biomedical simulators
Chen, C., Zhou, L., Kou, N., Li, X., Mao, H., & Liu, H. (2025) · Biofabrication · doi:10.1088/1758-5090/ae0dba · Cited by 11
Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells
Kim, M. S., Kim, H., & Lee, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303041 · Cited by 12
Rapid phagosome isolation enables unbiased multiomic analysis of human microglial phagosomes
Wogram, E., Sümpelmann, F., Dong, W., Rawat, E. S., Fernández-Maestre, I., Fu, D., Braswell, B., Khalil, A. S., Buescher, J. M., Mittler, G., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.019 · Cited by 12
Self-citationDuan, W., Li, T., & Liu, R. H. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104864 · Cited by 18
Wegner, V. D., Feile, A., Alb, M., Hudecek, M., Hewitt, P. G., & Mosig, A. S. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202405003 · Cited by 15
Human mini-brains for reconstituting central nervous system disorders
Kang, Y. J., Xue, Y., Shin, J. H., & Cho, H. (2023) · Lab on a Chip · doi:10.1039/d2lc00897a · Cited by 11
Developing organs-on-chips for biomedicine
Zhu, Y., Cai, L., Chen, H., & Zhao, Y. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.04.012 · Cited by 12
Ex vivo and miniaturized in vitro models to study microbiota-gut-brain axis
Yata, V. K. (2024) · 3 Biotech · doi:10.1007/s13205-024-04126-z · Cited by 15
Rosell‐Cardona, C., Cryan, J. F., Clarke, G. A., & Kittel‐Schneider, S. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00749-z · Cited by 12
Metadata
- Authors
- Trapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., Mildrum, S., Hendricks, A., Levine, S., Muffat, J., Lee, M. J., Lauffenburger, D. A., Trumper, D., Jaenisch, R., & Griffith, L. G.
- Affiliations
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Whitehead Institute for Biomedical Research (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Jaenisch, Rudolf
- Griffith, Linda G.
- ORCID
- Venue
- Science Advances
- Published
- 2021-01-29
- Volume
- 7
- Issue
- 5
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC7846169
- OpenAlex
- W3124669815
- Cited by
- 176
- References
- 96
- Citations by year
- 2026: 30 · 2025: 33 · 2024: 47 · 2023: 30 · 2022: 21 · 2021: 14
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (P30DK034854)
- National Institute of Environmental Health Sciences (P30-ES002109)
- Defense Sciences Office, DARPA (W911NF-12-2-0039)
- Korea National Institute of Health (R01EB021908)
- Army Research Office Institute for Collaborative Biotechnologies (W911NF-19-2-0026)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- microphysiological systems, gut-liver-brain axis, neurodegenerative diseases, Parkinson's disease, A53T mutation, regulatory T cells, Th17 cells, microbiome, short-chain fatty acids, systemic interactions
- MeSH terms
- Brain, Humans, Liver, Parkinson Disease, Neurodegenerative Diseases, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.